Before heart disease even develops among patients with heart disease, the effects on life expectancy have already begun, found researchers.

Simple, stupid: Too much TV, sedentary lifestyle and not meeting public health recommendations for physical activity.

A controlled release formulation of topiramate is effective adjunctive therapy for weight loss in obese type 2 diabetics treated with diet and exercise alone or in combination with metformin, researchers report in the June issue of Diabetes Care.

The synthetic form of a hormone previously found to produce a feeling of fullness when eating and reduce body weight, also may help curb binge eating and the desire to eat high-fat foods and sweets.

Obesity, metabolic syndrome traits, and parental diabetes predict the development of type 2 diabetes in middle-aged adults.

Patients with type 2 diabetes who have periodontitis are more likely than other diabetic patients to develop kidney disease, including end-stage renal failure.

Nonalcoholic fatty liver disease (NAFLD) is common in type 2 diabetes patients and is associated with a high prevalence of cardiovascular disease (CVD), according to new findings.

Acanthosis nigricans is an independent risk factor for type 2 diabetes, and its presence may help primary care clinicians identify high-risk patients with diabetes sooner, according to the results of a cross-sectional study.

The advanced glycation end product inhibitor LR-90 has anti-inflammatory properties that may protect against diabetic vascular complications.

Published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study showed Diachrome®, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).